Lecture on Recent advancements in Alzheimer’s disease trials & biomarkers
Title: Recent advancements in Alzheimer’s disease trials & biomarkers
Randall J. Bateman, M.D. is the Charles F. and Joanne Knight Distinguished Professor of Neurology, Director of the Dominantly Inherited Alzheimer Network (DIAN, http://dian.wustl.edu), and Director of the DIAN Trials Unit (DIAN-TU). Dr. Bateman’s laboratory focuses on the causes, diagnosis, and future treatments of AD. They directly measure the pathology and pathophysiology of AD in humans using multiple techniques. The group uses a wide variety of assays and techniques from the most basic applications, such as quantitative measurement of stable-isotope labeled peptides, to clinical translational studies in diagnostic and therapeutic biomarkers for AD. Dr. Bateman has been the primary mentor for more than twenty junior faculty, clinical fellows, post- docs and students who have been successful in their desired medical and scientific careers.
Start date: | |
---|---|
Time: | |
End time: | |
Location: | Online |
Costs: | Participation is for free. Meeting link: please contact Alzheimer Center via e-mail: projectbureau-alzheimercentrum@amsterdamumc.nl |
---|
Organisor |
Organized by Philip Scheltens, Pieter Jelle Visser, Marissa Zwan, Lisa Vermunt, Alzheimer Center |
---|---|
Contact | l.vermunt@amsterdamumc.nl |